ReviewCurrent oncology (Toronto, Ont.)2023

Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion.

Cesare Gridelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.